Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

ASH 2024 Insights: Secondary Heme Malignancies in Myeloma Post-CAR-T…

2024 ASH Annual Meeting Insights Hub

J. Waldschmidt

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

Practical Approach to MRD Monitoring in AML: Assessing Treatment Eff…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

AML: Current Treatment Landscape and Key Recent Updates

UChicago Medicine

A. Patel

AML: Diagnosis, Trends, and Approaches

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Percival

SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center

5th SOHO Italy Annual Conference

H. Kantarjian

Choosing the Right Treatment For the Right Patient in AML

Adriano Venditti

Characterization and Diagnosis of BPDCN

5th SOHO Italy Annual Conference

S. Fraticelli

Current & Emerging Therapies for AML and MDS

Indy Hematology Review

R. Komrokji

Navigating Hereditary Hematologic Malignancy Genetics

Oncology Data Advisor

S. Bannon, H. Abdel-Salam

Managing Intensive-Chemotherapy Ineligible Patients With AML

Scripps Health

C. DiNardo

A 50-Year Personal Perspective on the Treatment of AML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Schiffer

AML Case-Based Discussion: Managing Oncologic Emergencies and Decidi…

University of Colorado Division of Hematology

M. Beaton

SOHO 2023: Update on CHIP and CCUS

SOHO 2023 Eleventh Annual Meeting

L. Weeks

Acute Promyelocytic Leukemia: Risk Stratification and New Treatment …

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

S. ÇAkı Kılıç

Experts Discuss Current and Future Management of AML

MyCancerHaven

R. Vij, N. Daver

Pediatric AML: Diagnosis and Risk Stratification

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

N. Karadaş

Oncological Emergencies in AML

University of Colorado Division of Hematology

G. Peterson

Current Management of APL and AML

University of Colorado Division of Hematology

K. Halsema